Clear Street analyst Kaveri Pohlman raised the price target on Rapt Therapeutics (NASDAQ: RAPT) to $24.00 (from $3.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE